Delisting riskPopularity #4,921
ELUT · NASDAQ · Biotechnology

Elutia (ELUT)

Develops drug-eluting biomatrices for surgical reconstruction and implanted-device complications.

$0.8102
After-hours close0.00 (0.00%)
At close$0.8102(−5.06%)

13F · 13D/G · Form 4

Insiders21.62%9.58M shares
8 holders · as of Sep 14, 2026
Strategic holders21.50%9.52M shares
1 holder · as of Mar 13, 2025
Other56.88%25.19M shares
remainder

44.29M company shares as of Sep 23, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
HighCape Capital, L.P.Strategicdirector, 10 percent owner
21.50%9.52Mfiled Mar 13, 2025
Kevin Rakin1Insiderdirector, 10 percent owner
11.84%5.24Mfiled Jun 2, 2026
Nantahala Capital Management, LLCInstitution
9.31%4.12Mfiled Feb 13, 2026
Orin HirschmanInsider
6.93%3.07Mfiled Jan 28, 2026
Knollwood Investment Advisory, LLCInstitution
5.77%2.56Mfiled Feb 13, 2026
Matthew FergusonInsiderofficer: CHIEF FINANCIAL OFFICER
1.11%489,903filed Sep 14, 2026
C. Randal MillsInsiderdirector, officer: PRESIDENT AND CEO
1.05%464,395filed Sep 14, 2026
Michelle LeRoux WilliamsInsiderofficer: CHIEF SCIENTIFIC OFFICER
0.29%126,283filed Sep 14, 2026
Guido J. NeelsInsiderdirector
0.28%125,000filed Apr 14, 2026
David ColpmanInsiderdirector
0.07%31,098filed Dec 18, 2025
Brigid MakesInsiderdirector
0.06%27,000filed Dec 18, 2025
HighCape Capital, LLC2Strategic10 percent owner
20.55%9.10Mfiled Aug 1, 2024
Birchview Capital, LP3Strategicother: 10% Owner in previous filing
3.74%1.66Mfiled Feb 20, 2024
  1. Kevin Rakin's transaction reports restate only vehicles that traded; the 2025 ownership statement (5.24M) is used instead.
  2. Last filed Aug 1, 2024; leaving the company requires no filing. Not in the bar.
  3. Last filed Feb 20, 2024; leaving the company requires no filing. Not in the bar.

13F

No 13F holders on record.

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Kevin Rakinincl. HighCape Partners GP II, L.P., HighCape Partners, L.P. +7 more13.00%5.24M13DDec 15, 2025
Nantahala Capital Management, LLC9.99%4.12M13GFeb 13, 2026
Orin Hirschman7.60%3.07M13GJan 28, 2026
Knollwood Investment Advisory, LLC6.30%2.56M13GFeb 13, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jan 30, 2026
Guido J. Neelsdirector
Purchase20,000$1.04118,750
Jan 30, 2026
Kevin Rakindirector, 10 percent owner:
Purchase70,000$1.06196,120
Jan 28, 2026
Guido J. Neelsdirector
Purchase15,000$1.0683,750
Jan 29, 2026
Guido J. Neelsdirector
Purchase15,000$1.0698,750
Dec 17, 2025
Kevin Rakindirector, 10 percent owner:
Purchase50,000$0.5199322,419
Dec 17, 2025
Matthew Fergusonofficer: CHIEF FINANCIAL OFFICER
Purchase60,000$0.5300447,110
Dec 17, 2025
C. Randal Millsdirector, officer: PRESIDENT AND CEO
Purchase3,000$0.5100379,204
Dec 17, 2025
Brigid Makesdirector
Purchase25,000$0.520027,000
Dec 17, 2025
David Colpmandirector
Purchase12,500$0.510031,098
Dec 1, 2025
Matthew Fergusonofficer: CHIEF FINANCIAL OFFICER
Purchase4,500$0.6500373,571

House and Senate disclosures

Not reported.